The Overactive Bladder: Epidemiology and Morbidity

Urologic Clinics of North America

Volumn 33, Issue 4, 2006, Pages 433-438

  Tyagi, Shachi ^a   Thomas, Catherine A ^a   Hayashi, Yukio ^b   Chancellor, Michael B ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; CENTRAL NERVOUS SYSTEM DISEASE; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; FALL RISK; FRANCE; HEALTH CARE COST; HEALTH SURVEY; HUMAN; INTERSTITIAL CYSTITIS; MORBIDITY; OVERACTIVE BLADDER; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SEX DIFFERENCE; SEXUAL FUNCTION; SLEEP DISORDER; STRESS INCONTINENCE; UNITED STATES;

HUMANS; QUALITY OF LIFE; URINARY BLADDER, OVERACTIVE;

EID: 33748985816     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ucl.2006.06.002     Document Type: Review

References (25)

1. Wein A.J., and Rovner E.S. Definition and epidemiology of overactive bladder. Urology 60 5 Suppl. 1 (2002) 7-12 [discussion: 12]
2. Wagner T.H., et al. Health-related consequences of overactive bladder. Am J Manag Care 8 19 Suppl (2002) S598-S607
3. Hu T.W., et al. Costs of urinary incontinence and overactive bladder in the United States: a comparative study. Urology 63 3 (2004) 461-465
4. Hampel C., et al. [Epidemiology and etiology of overactive bladder]. Urologe A 42 6 (2003) 776-786 [German]
5. Milsom I., Stewart W., and Thuroff J. The prevalence of overactive bladder. Am J Manag Care 6 11 Suppl (2000) S565-S573
6. Milsom I., et al. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 87 9 (2001) 760-766
7. Tubaro A. Defining overactive bladder: epidemiology and burden of disease. Urology 64 6 Suppl. 1 (2004) 2-6
8. Coyne K.S., et al. The impact of urinary urgency and frequency on health-related quality of life in overactive bladder: results from a national community survey. Value Health 7 4 (2004) 455-463
9. Teleman P.M., et al. Overactive bladder: prevalence, risk factors and relation to stress incontinence in middle-aged women. Br J Obstet Gynaecol 111 6 (2004) 600-604
10. Asplund R. Nocturia in relation to sleep, health, and medical treatment in the elderly. BJU Int 96 Suppl 1 (2005) 15-21
11. Darkow T., Fontes C.L., and Williamson T.E. Costs associated with the management of overactive bladder and related comorbidities. Pharmacotherapy 25 4 (2005) 511-519
12. Brown J.S., McGhan W.F., and Chokroverty S. Comorbidities associated with overactive bladder. Am J Manag Care 6 11 Suppl (2000) S574-S579
13. Yu Y.F., et al. Persistence and adherence of medications for chronic overactive bladder/urinary incontinence in the California Medicaid program. Value Health 8 4 (2005) 495-505
14. Tubaro A., and Palleschi G. Overactive bladder: epidemiology and social impact. Curr Opin Obstet Gynecol 17 5 (2005) 507-511
15. Abrams P. Urgency: the key to defining the overactive bladder. BJU Int 96 Suppl 1 (2005) 1-3
16. Stewart W.F., et al. Prevalence and burden of overactive bladder in the United States. World J Urol 20 6 (2003) 327-336
17. Aslan G., et al. Sexual function in women with urinary incontinence. Int J Impot Res 17 3 (2005) 248-251
18. Kim Y.H., Seo J.T., and Yoon H. The effect of overactive bladder syndrome on the sexual quality of life in Korean young and middle aged women. Int J Impot Res 17 2 (2005) 158-163
19. Liberman J.N., et al. Health-related quality of life among adults with symptoms of overactive bladder: results from a US community-based survey. Urology 57 6 (2001) 1044-1050
20. Kobelt G. Economic considerations and outcome measurement in urge incontinence. Urology 50 6A Suppl (1997) 100-107 [discussion: 108-10]
21. Papanicolaou S., et al. Assessment of bothersomeness and impact on quality of life of urinary incontinence in women in France, Germany, Spain and the UK. BJU Int 96 6 (2005) 831-838
22. MacDiarmid S., and Rosenberg M. Overactive bladder in women: symptom impact and treatment expectations. Curr Med Res Opin 21 9 (2005) 1413-1421
23. Abrams P., et al. Overactive bladder significantly affects quality of life. Am J Manag Care 6 11 Suppl (2000) S580-S590
24. Kelleher C.J., et al. A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol 104 12 (1997) 1374-1379
25. Ross S., et al. Incontinence-specific quality of life measures used in trials of treatments for female urinary incontinence: a systematic review. Int Urogynecol J Pelvic Floor Dysfunct 17 3 (2006) 272-285